RE:

From: Grossman, Michael <MGrossman_at_gc.cuny.edu>
Date: Sun, 27 May 2012 19:26:21 -0400

The message below had the incorrect e-mail address for Ernie Bernet in the Cc. His correct address is eberendt_at_mit.edu<mailto:eberendt_at_mit.edu>
Michael Grossman
National Bureau of Economic Research
365 Fifth Avenue, 5th Floor
New York, New York 10016-4309
212-817-7959 (phone)
212-817-1597 (fax)
mgrossman_at_gc.cuny.edu<mailto:mgrossman_at_gc.cuny.edu> (e-mail)
https://wfs.gc.cuny.edu/MGrossman/www/ (home page)

________________________________
From: Grossman, Michael
Sent: Sunday, May 27, 2012 7:17 PM
To: Economics, Health
Cc: eberendt_at_mi.edu
Subject: FW:

Please see the message below from Ernie Berndt. If you are interested in the data in his message, please inform him.
Michael Grossman
National Bureau of Economic Research
365 Fifth Avenue, 5th Floor
New York, New York 10016-4309
212-817-7959 (phone)
212-817-1597 (fax)
mgrossman_at_gc.cuny.edu<mailto:mgrossman_at_gc.cuny.edu> (e-mail)
https://wfs.gc.cuny.edu/MGrossman/www/ (home page)

________________________________
From: Ernst R Berndt [erberndt_at_MIT.EDU]
Sent: Thursday, May 24, 2012 2:59 PM
To: Alterra Milone; Amy Finkelstein; Daniel Feenberg; dwise72037_at_aol.com; cockburn_at_bu.edu; Jonathan Gruber; jlerner_at_hbs.edu; Grossman, Michael; Nancy L Rose; nbloom_at_stanford.edu; chetty_at_fas.harvard.edu
Cc: RFrankel_at_us.imshealth.com; James M Poterba
Subject: FW:

Dear Alterra, Amy, Dan, David, Iain, Jon, Josh, Michael, Nancy, Nick, and Raj:

Negotiations have been taking place over the last few months with IMS Health and the IMS Institute for Healthcare Informatics (“IMS”) regarding the possibility of IMS making available to NBER family researchers some of IMS’ considerable data assets for purposes of academic research. These data assets include US National Sales Perspective (monthly, based on manufacturers’ and wholesalers’ invoices to various dispensing organizations), US National Prescription Audit (monthly, prescriptions dispensed from retail, mail, long term care to cash, Medicare Part D, Medicaid and commercial customers), US Xponent (monthly prescription data from retail and mail order pharmacies identified by prescriber DEA ID with possible links to AMA Master File), US National Disease and Therapeutic Index (quarterly physician office visits resulting in drug mention, stratified by ICD9 diagnosis codes and by drug), MIDAS (global data base for over 100 countries, analogous to the US National Prescription Audit – some countries monthly, others quarterly), HCOS (a relational data base linking US prescribers to affiliated provider networks, hospitals, payers – US only, annual for only a few years), Life Link claims data (longitudinal outpatient medical claims data) and CMD (charge master data base – longitudinal data on US hospitals’ claims and billings); I have considerably more detail available on these and several other IMS data bases – let me know if you want that information, and/or a bibliography of published studies using IMS data sets, and I can forward on to you.

Negotiations are moving forward with IMS, but the precise nature of the data access agreement has not yet been fully worked out. Randy Frankel, VP of External Affairs at IMS, will be coming to the NBER’s Cambridge office on Tuesday, June 5, at 2 pm to discuss the parameters of an IMS-NBER arrangement; he’ll be forwarding us a draft contract/letter of agreement a few days before then.

Thanks.

Ernie
Received on Sun May 27 2012 - 19:26:21 EDT